Beijing Scitop Bio-tech Co Ltd
SZSE:300858
Net Margin
Beijing Scitop Bio-tech Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 3.9B CNY |
| Net Margin |
32%
|
| Country | JP |
| Market Cap | 53.2T JPY |
| Net Margin |
4%
|
| Country | CH |
| Market Cap | 256.9B CHF |
| Net Margin |
12%
|
| Country | US |
| Market Cap | 91.1B USD |
| Net Margin |
12%
|
| Country | FR |
| Market Cap | 38.5B EUR |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 41.7B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 39.6B USD |
| Net Margin |
18%
|
| Country | US |
| Market Cap | 38.1B USD |
| Net Margin |
13%
|
| Country | CN |
| Market Cap | 255.8B CNY |
| Net Margin |
-5%
|
| Country | ZA |
| Market Cap | 30.6B Zac |
| Net Margin |
7%
|
| Country | ZA |
| Market Cap | 29.2B Zac |
| Net Margin |
13%
|
Profitability Report
View the profitability report to see the full profitability analysis for Beijing Scitop Bio-tech Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Beijing Scitop Bio-tech Co Ltd's most recent financial statements, the company has Net Margin of 32.1%.
You don't have any saved screeners yet
